Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1370)
CRISPR Therapeutics AG (CRSP)
KASINGER JAMES R. — General Counsel and Secretary
Shares
3,182
Price
$46.78
Total Value
$148.85K
Shares Held After
94,308
% of Holdings
3.3%
CRISPR Therapeutics AG (CRSP)
Prasad Raju — Chief Financial Officer
Shares
3,708
Price
$46.78
Total Value
$173.46K
Shares Held After
15,565
% of Holdings
19.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
370
Price
$536.16
Total Value
$198.38K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
830
Price
$535.12
Total Value
$444.15K
Shares Held After
40,883
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$533.93
Total Value
$491.22K
Shares Held After
41,713
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
364
Price
$533.15
Total Value
$194.07K
Shares Held After
42,633
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
671
Price
$531.65
Total Value
$356.74K
Shares Held After
42,997
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
703
Price
$530.91
Total Value
$373.23K
Shares Held After
43,668
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
342
Price
$529.80
Total Value
$181.19K
Shares Held After
44,371
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$527.57
Total Value
$63.31K
Shares Held After
44,713
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$526.59
Total Value
$337.01K
Shares Held After
44,833
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$525.43
Total Value
$210.17K
Shares Held After
45,473
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
647
Price
$524.15
Total Value
$339.12K
Shares Held After
45,873
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$522.19
Total Value
$83.55K
Shares Held After
46,520
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,320
Price
$521.38
Total Value
$688.22K
Shares Held After
46,680
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
867
Price
$520.54
Total Value
$451.31K
Shares Held After
48,000
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
906
Price
$519.29
Total Value
$470.48K
Shares Held After
48,867
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$518.39
Total Value
$124.41K
Shares Held After
49,773
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
Olian Judy D. — Director
Shares
200
Price
$530.00
Total Value
$106.00K
Shares Held After
4,245
% of Holdings
4.5%
Vir Biotechnology, Inc. (VIR)
Sabatini Brent — SVP, Chief Accounting Officer
Shares
7,711
Price
$9.12
Total Value
$70.32K
Shares Held After
61,902
% of Holdings
11.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
160
Price
$536.27
Total Value
$85.80K
Shares Held After
18,876
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$535.34
Total Value
$235.55K
Shares Held After
19,036
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
506
Price
$534.60
Total Value
$270.51K
Shares Held After
19,476
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
642
Price
$533.60
Total Value
$342.57K
Shares Held After
19,982
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
288
Price
$532.59
Total Value
$153.39K
Shares Held After
20,624
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
587
Price
$531.49
Total Value
$311.98K
Shares Held After
20,912
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
577
Price
$530.64
Total Value
$306.18K
Shares Held After
21,499
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,620
Price
$529.04
Total Value
$1.39M
Shares Held After
22,076
% of Holdings
10.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$527.49
Total Value
$42.20K
Shares Held After
24,696
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
520
Price
$526.57
Total Value
$273.82K
Shares Held After
24,776
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
320
Price
$525.37
Total Value
$168.12K
Shares Held After
25,296
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$524.20
Total Value
$230.65K
Shares Held After
25,616
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
200
Price
$522.36
Total Value
$104.47K
Shares Held After
26,056
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
905
Price
$521.47
Total Value
$471.93K
Shares Held After
26,256
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
875
Price
$520.62
Total Value
$455.54K
Shares Held After
27,161
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
640
Price
$519.30
Total Value
$332.35K
Shares Held After
28,036
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
200
Price
$518.28
Total Value
$103.66K
Shares Held After
28,676
% of Holdings
0.7%
Immunome Inc. (IMNM)
WAGENHEIM PHILIP — Director
Shares
28,200
Price
$20.65
Total Value
$582.33K
Shares Held After
341,147
% of Holdings
7.6%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.83
Total Value
$263.60K
Shares Held After
481,906
% of Holdings
3.8%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
11,628
Price
$0.85
Total Value
$9.86K
Shares Held After
3,871,996
% of Holdings
0.3%
4D Molecular Therapeutics, Inc. (FDMT)
Gupta Ashoo — VP, Finance and Controller
Shares
80
Price
$8.61
Total Value
$688.80
Shares Held After
47,055
% of Holdings
0.2%
4D Molecular Therapeutics, Inc. (FDMT)
Gupta Ashoo — VP, Finance and Controller
Shares
310
Price
$8.61
Total Value
$2.67K
Shares Held After
46,914
% of Holdings
0.7%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
4,233
Price
$0.85
Total Value
$3.59K
Shares Held After
1,811,767
% of Holdings
0.2%
Quantum-Si Inc (QSI)
LaPointe Christian — GC & Corp. Secretary
Shares
5,849
Price
$0.85
Total Value
$4.96K
Shares Held After
1,204,127
% of Holdings
0.5%
Quantum-Si Inc (QSI)
Vieceli John S. — Chief Product Officer
Shares
10,758
Price
$0.85
Total Value
$9.13K
Shares Held After
1,181,896
% of Holdings
0.9%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
11,767
Price
$36.01
Total Value
$423.73K
Shares Held After
2,231
% of Holdings
84.1%
Tarsus Pharmaceuticals, Inc. (TARS)
Neervannan Seshadri — Chief Operating Officer
Shares
2,989
Price
$66.75
Total Value
$199.52K
Shares Held After
82,791
% of Holdings
3.5%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
601
Price
$34.41
Total Value
$20.68K
Shares Held After
19,543
% of Holdings
3.0%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
8,692
Price
$33.64
Total Value
$292.36K
Shares Held After
20,144
% of Holdings
30.1%
BIOCRYST PHARMACEUTICALS INC (BCRX)
HEGGIE THERESA — Director
Shares
49,933
Price
$10.11
Total Value
$504.82K
Shares Held After
65,352
% of Holdings
43.3%
Showing 51–100 of 1370 transactions (page 2 of 28)